Picture of Telyrx Holdings logo

TELY Telyrx Holdings Share Price

0.000.00%
ca flag iconLast trade - 00:00
Consumer CyclicalsSpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-1.33%
3m-4.09%
6m-9.78%
1yrn/a
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-28.71%
50d MA-4.5%
200d MA-4.5%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-30.19%
Return on Equity-58.37%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202631st Dec 2027
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2026 / 2027

Blurred out image of Telyrx Holdings EPS forecast chart

Profile Summary

TelyRx Holdings Inc. is a technology-enabled healthcare and pharmacy services company operating a digital pharmacy platform. Connecting patients with independent, state-licensed providers to access over 350 everyday medications across 48 states and territories in the United States, the Company fulfills prescriptions through licensed retail pharmacies in Florida and Texas, delivering medication directly. The Company's product categories include flu and infections, chronic conditions, digestive and travel, skin and hair, women's health, men's health, lifestyle, weight loss, doctor's notes, pets, and supplements. The Company's chronic conditions product categories include allergies, asthma, diabetes, dry eye, gingivitis, glaucoma, high cholesterol, and migraine. The Company's flu and infections product categories include anti-fungal, cold and flu, cold sores, ear and eye infections and herpes. Its doctor's notes product categories include excuse note and emotional support animal letter.

Directors

    Last Annual
    December 31st, 2025
    Last Interim
    December 31st, 2025
    Incorporated
    April 2nd, 2025
    Public Since
    October 24th, 2025
    Sector
    Diversified Retail
    Industry
    Consumer Cyclicals
    Exchange
    ca flag iconToronto Stock Exchange
    Shares in Issue
    26,353,729

    TELY Share Price Performance

    Similar to TELY

    Picture of BMTC logo

    BMTC

    ca flag iconToronto Stock Exchange

    Picture of Canadian Tire logo

    Canadian Tire

    ca flag iconToronto Stock Exchange

    Picture of Dollarama logo

    Dollarama

    ca flag iconToronto Stock Exchange

    FAQ